Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria

Journal of Clinical Microbiology

Volumn 50, Issue 9, 2012, Pages 2905-2909

  Dinic, Lana ^a   Akande, Patrick ^b   Idigbe, Emmanuel Oni ^d   Ani, Agatha ^c   Onwujekwe, Dan ^d   Agbaji, Oche ^c   Akanbi, Maxwell ^c   Nwosu, Rita ^d   Adeniyi, Bukola ^c   Wahab, Maureen ^d   Lekuk, Chindak ^c   Kunle Ope, Chioma ^d   Nwokoye, Nkiru ^d   Kanki, Phyllis ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b APIN PUBLIC HEALTH INITIATIVES   (Nigeria)

^c UNIVERSITY OF JOS   (Nigeria)

^d NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ISONIAZID; RIFAMPICIN;

ADULT; ARTICLE; DISEASE ASSOCIATION; DRUG RESISTANT TUBERCULOSIS; FEMALE; GENE MUTATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NIGERIA; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPUTUM ANALYSIS;

ADULT; ANTITUBERCULAR AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; NIGERIA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865190581     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00982-12     Document Type: Article

References (37)

1. Andersson DI. 2006. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol. 9:461-465. (Pubitemid 44397630)
2. Anek-Vorapong R, et al. 2010. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect. Dis. 10:123. doi:10.1186/1471-2334-10-123.
3. Baker LV, et al. 2005. Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC-46A polymorphism. Antimicrob. Agents Chemother. 49:1455-1464. (Pubitemid 40463376)
4. Causse M, Ruiz P, Gutierrez JB, Zerolo J, Casal M. 2008. Evaluation of new GenoType MTBDRplus for detection of resistance in cultures and direct specimens of Mycobacterium tuberculosis. Int. J. Tuberc. Lung Dis. 12:1456-1460.
5. Chan ED, Iseman MD. 2008. Multidrug-resistant and extensively drug-resistant tuberculosis: a review. Curr. Opin. Infect. Dis. 21:587-595.
6. Dorman SE, Chaisson RE. 2007. From magic bullets back to the magic mountain: the rise of extensively drug-resistant tuberculosis. Nat. Med. 13:295-298. (Pubitemid 46376673)
7. Federal Ministry of Health Nigeria. 2011. Technical report: 2010 National HIV Sero-prevalance Sentinel Survey, p 1-110. Federal Ministry of Health, Abuja, Nigeria.
8. Gagneux S. 2009. Fitness cost of drug resistance in Mycobacterium tuberculosis. Clin. Microbiol. Infect. 15(Suppl 1):66-68.
9. Gagneux S, et al. 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis. Science 312:1944-1946. (Pubitemid 43993719)
10. Godfrey-Faussett P, et al. 2000. Tuberculosis control and molecular epidemiology in a South African gold-mining community. Lancet 356:1066-1071.
11. Hain Lifescience. 2009. GenoType MTBDRplus manual, p 23-42. In Molecular genetic assay for identification of resistance to rifampicin and/or isoniazid of the Mycobacterium tuberculosis complex. Hain Lifescience GmbH, Nehren, Germany.
12. Harries AD, et al. 2001. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet 357:1519-1523. (Pubitemid 32488877)
13. Harries AD, et al. 1998. Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi. Trans. R. Soc. Trop. Med. Hyg. 92:343-347. (Pubitemid 28286941)
14. Hazbon MH, et al. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50:2640-2649. (Pubitemid 44198682)
15. Huang WL, Chen HY, Kuo YM, Jou R. 2009. Performance assessment of the GenoType MTBDRplus test andDNAsequencing in detection of multidrug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 47:2520-2524.
16. Kim SY, et al. 2003. Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea. Diagn. Microbiol. Infect. Dis. 47:497-502.
17. Lacoma A, et al. 2008. GenoType MTBDRplus assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical samples. J. Clin. Microbiol. 46:3660-3667.
18. Mannheimer SB, et al. 1997. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic multidrug-resistant tuberculosis in New York City. Int. J. Tuberc. Lung Dis. 1:319-325. (Pubitemid 127509638)
19. Maxmen A. 2010. Fighting the monster. Nature 466:S18-S19.
20. Narvaiz de Kantor I, et al. 1998. Laboratory services in tuberculosis control. World Health Organization, Geneva, Switzerland.
21. Neonakis IK, et al. 2009. Evaluation of GenoType mycobacteria direct assay in comparison with Gen-Probe Mycobacterium tuberculosis amplified direct test and GenoType MTBDRplus for direct detection of Mycobacterium tuberculosis complex in clinical samples. J. Clin. Microbiol. 47:2601-2603.
22. NIAID. 2007. Scientific illustrations of drug-resistant TB. National Institute of Allergy and Infectious Diseases, Bethesda, MD. http://www.niaid. nih.gov/topics/tuberculosis/understanding/whatistb/scientificillustrations/ pages/multidrugresistantillustration.aspx.
23. Nikolayevskyy V, et al. 2009. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin. Pathol. 9:2. doi:10.1186/1472-6890-9-2.
24. Park MM, Davis AL, Schluger NW, Cohen H, Rom WN. 1996. Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am. J. Respir. Crit. Care Med. 153:317-324. (Pubitemid 26026869)
25. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79:3-29. (Pubitemid 29050434)
26. Rigouts L, et al. 2011. Evaluation of the GenoType® MTBDRplus assay as a tool for drug resistance surveys. Int. J. Tuberc. Lung Dis. 15:959-965.
27. Selwyn PA, et al. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545-550. (Pubitemid 19070537)
28. Selwyn PA, et al. 1992. High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA 268:504-509.
29. Smith SE, Kurbatova EV, Cavanaugh JS, Cegielski JP. 2012. Global isoniazid resistance patterns in rifampin-resistant and rifampinsusceptible tuberculosis. Int. J. Tuberc. Lung Dis. 16:203-205.
30. Strauss OJ, et al. 2008. Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. J. Clin. Microbiol. 46:1514-1516. (Pubitemid 351563605)
31. Suchindran S, Brouwer ES, Van Rie A. 2009. Is HIV infection a risk factor for multidrug resistant tuberculosis? A systematic review. PLoS One 4:e5561. doi:10.1371/journal.pone.0005561.
32. UNAIDS/World Health Organization. 2009. AIDS epidemic update December 2009. UNAIDS, Geneva, Switzerland.
33. Whalen CC, et al. 2000. Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS 14:1219-1228. (Pubitemid 30420666)
34. Global Tuberculosis Programme/WHO. 2003. Treatment of tuberculosis: guidelines for national programs, 3rd ed. World Health Organization, Geneva, Switzerland.
35. World Health Organization. 2007. The global MDR-TB and XDR-TB response plan. World Health Organization, Geneva, Switzerland.
36. World Health Organization. 2011. Nigeria: tuberculosis profile 2010. World Health Organization, Geneva, Switzerland. https://extranet.who.int/sree/ Reports?op=Replet&name=%2FWHO-HQ- Reports%2FG2%2FPROD%2FEXT%2FTBCountryProfile&ISO2=NG&outtype=html.
37. World Health Organization. 2010. Global tuberculosis control: WHO report 2010. World Health Organization, Geneva, Switzerland.